<DOC>
	<DOCNO>NCT01131897</DOCNO>
	<brief_summary>The purpose study compare single-dose relative bioavailability study Levetiracetam Tablets 750 mg KeppraÂ® 750 mg Tablets Fasting condition .</brief_summary>
	<brief_title>Bioavailability Study Levetiracetam Tablets , 750 mg Dr. Reddy 's Under Fasting Conditions .</brief_title>
	<detailed_description>This open-label , randomize , single-dose 2-way crossover relative bioavailability study healthy adult male volunteer fast condition washout period 7 day .</detailed_description>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Healthy adult male volunteer , 18 55 year age ; Weighing least 60 kg within 15 % ideal weight ( Table `` Desirable Wights Adults '' , Metropolitan Life Insurance Company , 1983 ) ; Medically healthy subject clinically normal laboratory profile ECGs deem principal investigator ; Voluntarily consent participate study History presence significant cardiovascular , pulmonary , hepatic , renal hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease . In addition , history presence : 1. alcoholism drug abuse within past 2 year ; 2. hypersensitivity idiosyncratic reaction levetiracetam ; Subjects special diet ( whatever reason ) 30 day prior first dose throughout study . Subjects make donation ( Standard donation amount ) blood blood product ( exception plasma note ) within 56 day prior first dose . Subjects make plasma donation within 7 day prior first dose . Subjects participate another clinical trial within 30 day prior first dose . Subjects hemoglobin less 12.0 g/dL . Subjects participate another clinical trial within 30 day prior first dose .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Crossover</keyword>
	<keyword>Levetiracetam</keyword>
</DOC>